Home » Reports » Broker Ratings » AstraZeneca plc 14.2% Potential Upside Indicated by Kepler Cheuvreux
broker ratings

AstraZeneca plc 14.2% Potential Upside Indicated by Kepler Cheuvreux

AstraZeneca plc with EPIC/TICKER (LON:AZN) had its stock rating noted as ‘Reiterates’ with the recommendation being set at ‘BUY’ today by analysts at Kepler Cheuvreux. AstraZeneca plc are listed in the Health Care sector within UK Main Market. Kepler Cheuvreux have set a target price of 5300 GBX on its stock. This would indicate that the analyst believes there is a potential upside of 14.2% from the opening price of 4642.5 GBX. Over the last 30 and 90 trading days the company share price has decreased 510.5 points and decreased 387.5 points respectively. The 52 week high for the share price is currently at 5520 GBX while the 52 week low is 4260 GBX.

AstraZeneca plc has a 50 day moving average of 5,015.68 GBX and the 200 Day Moving Average price is recorded at 5,011.75. There are currently 1,281,007,470 shares in issue with the average daily volume traded being 1,748,047. Market capitalisation for LON:AZN is £61,302,612,477 GBP.